Alpha DNA Investment Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-127	Closed	-$2K	–	464
2021 Q1	$2K	Buy	127 +45	+55%	+$709	﹤0.01%	572
2020 Q4	$1K	Buy	+82	New	+$1K	﹤0.01%	536